Reproductive Medicine
Novel PGD strategy improves muscular dystrophy diagnosis
Published in Health and Medicine Week, September 1st, 2003
Scientists in France "have developed a preimplantation genetic diagnosis (PGD) strategy for Duchenne muscular dystrophy (DMD) allowing the simultaneous amplification of four exons (6, 8, 28 and 32) of the dystrophin gene together with ZFX/ZFY genes for gender determination."
"Preliminary experiments were carried out on 215 single lymphocytes from male and female individuals," according to A. Girardet and coauthors at the University of Montpellier Hospital Center.
"Amplification rates ranged from 90.2% for exon 6 to 96.7% for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health and Medicine Week
More Articles from Health and Medicine Week
- Adolescent Medicine
Relationship-based intervention improves maternal sensitivity in young mothers - Tissue Engineering
Carnegie Mellon develops new process for growing bone - Complementary and Alternative Medicine
Brain scans, blood tests show positive effects of meditation - Exercise
Women benefit from physical activity during and after menopause - Fitness
Physical activity definitions broadened to include daily activities - HIV/AIDS Epidemiology
Prevalence of HIV infection increasing in older Americans - More from this issue of Health and Medicine Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
